MétaCan
Menu
← Back to cohort

Abstract A082 Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma

2024· article· en· W4402266275 on OpenAlexaboutno aff
Dong Wang, Breunna Brunt, Bethany Veo, Milena Mazan, Tomasz Rzmyski, Sujatha Venkataraman, Nathan Dahl, Rajeev Vibhakar

Bibliographic record

VenueCancer Research · 2024
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedulloblastomaCancer researchMedicine

Abstract

fetched live from OpenAlex

Abstract Medulloblastoma (MB) is a prevalent malignant pediatric brain tumor with high mortality rates despite currentmultimodal therapies. MYC-driven Group 3 MB represents a highly aggressive subgroup with poor prognosis and limited treatment options. To systematically identify genes representing therapeutic vulnerabilities in MYC-driven MB, we performed a CRISPR-Cas9 screen with a specific focus on 1140 druggable genes across three MB cell lines. CDK8 emerged as a significantly selected gene crucial for MYC-driven MB growth, for which clinically relevant inhibitors are in early phase trials. CDK8 gene expression is high in group 3 MB (Colorado cohort) and specifically high in MYC driven MB subtypes and elevated expression of CDK8 is an adverse prognostic marker even in high-risk group 3 tumors. CDK8 is highly expressed in progenitor populations identified in our recent single-cell RNA-seq analysis and similarly expressed in cycling progenitors in murine models of MB. CDK8 depletion in MB cells using CRISPR-Cas9-induced knockout and lentivirus-mediated CDK8 shRNAs resulted in decreased i cell proliferation and MYC protein. Additionally, CDK8 depletion significantly decreased neurosphere growth in MB cells and supressed orthotopic xenograft growth in vivo. Evaluation of eight CDK8 selective inhibitors demonstrated a broad range of half-maximal inhibitory concentrations (IC50) across three G3-MB cell lines with RVU120 showing the maximum potency, RVu120 supressed colony growth in vitro in MB cells but not normal astrocytes. In vivo RVU120 potently supressed growth of orthotopic xenografts as evaluated by MRI and prolonged survival. RNA-seq analysis revelaed that CDK8 depletion leads to repression of mRNA translation and ribosome biogenesis. GSEA indicated that the loss of CDK8 resulted in strong negative enrichment in the transcriptomic profile associated with stemness gene sets and positive enrichment in differentiation gene sets. We performed a genome-wide analysis to map the occupancy of CDK8 and key histone markers using CUT&RUN in three G3-MB cell lines. We found that CDK8 functions as a transcriptional activator affecting the translation program. In vitro, inhibition of protein tranlation via mTOR supression was synergistic with CDK8 inhibition. We found that this synthetic lethality was relevant in vivo,where CDK8i and mTORi combined to supress xenograft growth and prolong survival. Taken together, these studies established the therapeutic efficacy of combination treatment with mTOR and CDK8 inhibitors in vivo and in vitro, opening an alternate path for biologically based therapeutic trials in MYC-driven MB. Citation Format: Dong Wang, Breunna Brunt, Bethany Veo, Milena Mazan, Tomasz Rzmyski, Sujatha Venkataraman, Nathan Dahl, Rajeev Vibhakar. Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr A082.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.111
GPT teacher head0.413
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicGlioma Diagnosis and Treatment→French-language works237,207→